Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
Silvia Scoccianti et al.
NEURO-ONCOLOGY (2021)
Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter
Robert Thompson et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis
Luca Nicosia et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed
M. Milosevic et al.
COLORECTAL DISEASE (2020)
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases
Luca Nicosia et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy
Luca Nicosia et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2020)
Beyond Oligometastases
David A. Palma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
Takaya Yamamoto et al.
BMC CANCER (2020)
The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases
Rainer J. Klement et al.
BMC CANCER (2019)
Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy
Carlo Greco et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer
Gregory M. Videtic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy
Ciro Franzese et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer Prognostic Factors for Disease Control and Survival
Haoming Qiu et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review
J. Kobiela et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease
M. F. Osti et al.
LUNG CANCER (2018)
Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review
Fausto Petrelli et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
Wen-Chi Yang et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
Luca Triggiani et al.
BRITISH JOURNAL OF CANCER (2017)
Overall Survival and the Response to Radiotherapy Among Molecular Subtypes of Breast Cancer Brain Metastases Treated With Targeted Therapies
Jacob A. Miller et al.
CANCER (2017)
Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up
Linda Agolli et al.
CLINICAL COLORECTAL CANCER (2017)
The Prognosis of Pulmonary Metastasectomy Depends on the Location of the Primary Colorectal Cancer
Jong Ho Cho et al.
ANNALS OF THORACIC SURGERY (2014)
Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study
Maria Giulia Zampino et al.
ANNALS OF THORACIC SURGERY (2014)
Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller
Yangki Seok et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
History and present status of pulmonary metastasectomy in colorectal cancer
Tom Treasure et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases
Filippo Alongi et al.
ONCOLOGIST (2012)
STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OPERABLE STAGE I NON SMALL-CELL LUNG CANCER: CAN SBRT BE COMPARABLE TO SURGERY?
Hiroshi Onishi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Hepatic and extrahepatic colorectal metastases: When resectable, their localization does not matter, but their total number has a prognostic effect
D Elias et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Share Paper
